These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24431282)

  • 1. Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model.
    Wang B; Jin H; Zhu M; Li J; Zhao L; Zhang Y; Tang D; Xiao G; Xing L; Boyce BF; Chen D
    Arthritis Rheumatol; 2014 Jan; 66(1):107-20. PubMed ID: 24431282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis.
    Wen X; Li X; Tang Y; Tang J; Zhou S; Xie Y; Guo J; Yang J; Du X; Su N; Chen L
    J Biol Chem; 2016 Nov; 291(48):24912-24921. PubMed ID: 27729453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
    Honma M; Ikebuchi Y; Kariya Y; Suzuki H
    Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.
    Xu S; Zhang Y; Liu B; Li K; Huang B; Yan B; Zhang Z; Liang K; Jia C; Lin J; Zeng C; Cai D; Jin D; Jiang Y; Bai X
    J Bone Miner Res; 2016 Jul; 31(7):1320-33. PubMed ID: 26825871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
    Yang C; Liu W; Zhang X; Zeng B; Qian Y
    J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.
    Usui M; Xing L; Drissi H; Zuscik M; O'Keefe R; Chen D; Boyce BF
    J Bone Miner Res; 2008 Mar; 23(3):314-25. PubMed ID: 17967138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone.
    Wang B; Jin H; Shu B; Mira RR; Chen D
    Sci Rep; 2015 Sep; 5():13667. PubMed ID: 26329493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through β-catenin-dependent and -independent pathways.
    Zhang X; Zhu J; Li Y; Lin T; Siclari VA; Chandra A; Candela EM; Koyama E; Enomoto-Iwamoto M; Qin L
    J Biol Chem; 2013 Nov; 288(45):32229-32240. PubMed ID: 24047892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.
    Jang HD; Shin JH; Park DR; Hong JH; Yoon K; Ko R; Ko CY; Kim HS; Jeong D; Kim N; Lee SY
    J Biol Chem; 2011 Nov; 286(45):39043-50. PubMed ID: 21949120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
    Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
    PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
    Enomoto H; Shiojiri S; Hoshi K; Furuichi T; Fukuyama R; Yoshida CA; Kanatani N; Nakamura R; Mizuno A; Zanma A; Yano K; Yasuda H; Higashio K; Takada K; Komori T
    J Biol Chem; 2003 Jun; 278(26):23971-7. PubMed ID: 12697767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital Roles of β-catenin in Trans-differentiation of Chondrocytes to Bone Cells.
    Jing Y; Jing J; Wang K; Chan K; Harris SE; Hinton RJ; Feng JQ
    Int J Biol Sci; 2018; 14(1):1-9. PubMed ID: 29483820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
    Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
    J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of beta-catenin in postnatal bone acquisition.
    Holmen SL; Zylstra CR; Mukherjee A; Sigler RE; Faugere MC; Bouxsein ML; Deng L; Clemens TL; Williams BO
    J Biol Chem; 2005 Jun; 280(22):21162-8. PubMed ID: 15802266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice.
    Zhu M; Tang D; Wu Q; Hao S; Chen M; Xie C; Rosier RN; O'Keefe RJ; Zuscik M; Chen D
    J Bone Miner Res; 2009 Jan; 24(1):12-21. PubMed ID: 18767925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.